MSB 7.69% $1.19 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-1003

  1. 5,071 Posts.
    lightbulb Created with Sketch. 567
    and that was the last FDA respsone to lawmans in 2021? seem like there could be a not filed doco floating around some where, otherwise no repsonse may look like due course of process might not seen to be done, and allow lawman a door open to put in another object { regardless or merit ) to stop the approval just because of due process not had.
    Last edited by jwoody1000: 13/07/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.